BRIEF-4Sc: FDA Accepts IND Application For MERKLIN 2 Study

April 8 (Reuters) – 4SC AG:

* FDA ACCEPTS IND APPLICATION FOR MERKLIN 2 STUDY

* INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR DOMATINOSTAT IN COMBINATION WITH AVELUMAB (BAVENCIO(R)) HAS BEEN ACCEPTED BY U.S. FOOD AND DRUG ADMINISTRATION (FDA) Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Leave a Reply